Clinical trial
Combination Versus Monotherapy With Alpha Blocker and Anticholinergics to Relieve Urinary Stent Symptoms
NCT01741454 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Combination Versus Monotherapy With Alpha Blocker and Anticholinergics to Relieve Urinary Stent Symptoms
- Lead sponsor
- University of Wisconsin, Madison
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2012
- Completion date
- March 30, 2018
- Enrollment
- 181 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.